info@synchemia.com | sales@synchemia.com 
9766925136 
Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0143971 |
| CAS No | NA |
| Mol.F. | C7H9N3O |
| Mol.Wt. | 151.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143972 |
| CAS No | NA |
| Mol.F. | C6H8N4O3 |
| Mol.Wt. | 184.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143973 |
| CAS No | NA |
| Mol.F. | C7H14N2O2 |
| Mol.Wt. | 158.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143974 |
| CAS No | NA |
| Mol.F. | C8H10N2O |
| Mol.Wt. | 150.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143975 |
| CAS No | NA |
| Mol.F. | C5H8N2O2 |
| Mol.Wt. | 128.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143976 |
| CAS No | NA |
| Mol.F. | C4H5N3O |
| Mol.Wt. | 111.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143977 |
| CAS No | 1822857-11-3 |
| Mol.F. | C5H12N2O2 |
| Mol.Wt. | 132.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143978 |
| CAS No | NA |
| Mol.F. | C4H10ClN3O |
| Mol.Wt. | 151.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143979 |
| CAS No | 83008-57-5 |
| Mol.F. | C3H8N4O |
| Mol.Wt. | 116.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143980 |
| CAS No | 1354380-71-4 |
| Mol.F. | C3H7N5O2 |
| Mol.Wt. | 145.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143981 |
| CAS No | NA |
| Mol.F. | C6H14N4O |
| Mol.Wt. | 158.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143982 |
| CAS No | NA |
| Mol.F. | C13H17N5O |
| Mol.Wt. | 259.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143983 |
| CAS No | 52764-44-0 |
| Mol.F. | C5H12N4O |
| Mol.Wt. | 144.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143984 |
| CAS No | NA |
| Mol.F. | C8H14N6O2 |
| Mol.Wt. | 226.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143985 |
| CAS No | NA |
| Mol.F. | CH3N3O2 |
| Mol.Wt. | 89.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143986 |
| CAS No | NA |
| Mol.F. | C6H8N4O3 |
| Mol.Wt. | 184.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
